- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
- 10-K Annual report
- 3.1 Restated Certificate of Incorporation of the Registrant, As Amended.
- 10.6 Summary of Director Compensation
- 10.7 Summary of 2011 Bonus Targets
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of CEO and President Pursuant to Exchange Act Rule 13A-14(A)
- 31.2 Certification of CFO Pursuant to Exchange Act Rule 13A-14(A)
- 32.1 Certification of CEO and President Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification of the CFO Pursuant to 18 U.s.c. Section 1350
EXHIBIT 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Icagen, Inc. (the “Company”) for the period ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, P. Kay Wagoner, Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: March 9, 2011 | /s/ P. Kay Wagoner | |
| P. Kay Wagoner, Ph.D. | ||
| Chief Executive Officer |